Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 2D-to-3D Culture and Organoids 2020


3D Bioprinting for Cancer Research

Shubhankar Nath, Senior Oncology Scientist, CELLINK

The presentation will discuss recent advancements in the area of cancer model development utilizing 3D bioprinting technologies. Physiologically relevant 3D cancer models are critical for drug discoveries. These 3D cancer models predict the outcome of in vivo experiments that 2D models often fail. The use of 3D cell culture, aided by CELLINK’s bioprinting technologies, affords the use of multicellular constructs in the presence of tissue-specific extracellular matrix to better mimic the in vivo milieu. These cancer models are also used to study the interactions between cancer cells and their microenvironment to develop mechanism-informed therapies.

Add to Calendar ▼2020-08-19 00:00:002020-08-20 00:00:00Europe/London2D-to-3D Culture and Organoids 20202D-to-3D Culture and Organoids 2020 in Boston, USABoston,